Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Queensland Health
Teva
Daiichi Sankyo
Johnson and Johnson
Chinese Patent Office
Accenture
Novartis
Farmers Insurance
McKesson

Generated: February 24, 2018

DrugPatentWatch Database Preview

Disopyramide phosphate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for disopyramide phosphate and what is the scope of disopyramide phosphate patent protection?

Disopyramide phosphate
is the generic ingredient in three branded drugs marketed by Nesher Pharms, Gd Searle Llc, Aurolife Pharma Llc, Interpharm, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Sun Pharm Industries, Superpharm, Teva, and Watson Labs, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for disopyramide phosphate. Seven suppliers are listed for this compound.
Pharmacology for disopyramide phosphate
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for disopyramide phosphate

US Patents and Regulatory Information for disopyramide phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070352-001 Dec 17, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mayne Pharma DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070173-001 May 31, 1985 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Interpharm DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 071190-001 Jan 15, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070240-001 Feb 2, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070187-001 Nov 18, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc NORPACE CR disopyramide phosphate CAPSULE, EXTENDED RELEASE;ORAL 018655-001 Jul 20, 1982 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Superpharm DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070940-001 Feb 9, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070186-001 Nov 18, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Interpharm DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 071191-001 Jan 15, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc NORPACE disopyramide phosphate CAPSULE;ORAL 017447-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Healthtrust
McKinsey
Harvard Business School
Cantor Fitzgerald
Moodys
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot